Submit Abstract

Poster Abstracts Submission

  • Home
  • Poster Abstracts Submission

Call for Abstracts

Abstract Submissions

Abstract submissions are welcomed from neuroscientists, clinicians, researchers, trainees, and students across all areas of neuroscience, neurodevelopment, neurogenetics, and neurological disorders. Submissions related to autism spectrum disorder, Fragile X–associated conditions, and translational neuroscience are especially encouraged.

All abstracts will be peer-reviewed by the Scientific Committee. Selected submissions will be invited for poster presentation during the conference.

Submit Abstract

Abstract Submission Guidelines

General Requirements & Word Count

Word Limit: 250–350 words

(Recommended length: 250–300 words)

Please prepare your abstract as one cohesive narrative that clearly tells the story of your project:

  • Begin by briefly introducing the problem, knowledge gap, or clinical context and explain why it is important.

  • Clearly state your objective in one sentence using a strong action verb (e.g., evaluate, examine, investigate, implement, assess).

  • Concisely describe the study design, population/sample, and key methods.

In the second half of your abstract:

  • Present your primary findings with specific results. Avoid vague statements such as “results were significant” without clarification.

  • Conclude with a clear statement explaining what the findings mean and their implications for clinical practice, research, education, or policy.

  • Ensure alignment between your objective, methods, results, and conclusion.

Are You Ready?

Join a global community shaping the future of neurodevelopmental research, care, and advocacy.

Submit Abstract

Pharmacist, Scientist & Higher-Education Leader

Dr. Reem Olaby

Dr. Reem Olaby is a pharmacist, scientist, and higher-education leader actively engaged in curriculum reform, faculty development, and academic governance.

Her scholarly work focuses on the genetic, epigenetic, and proteomic underpinnings of neurodevelopmental and neurodegenerative disorders, including autism spectrum disorder (ASD), Fragile X syndrome (FXS), and Fragile X–associated tremor/ataxia syndrome (FXTAS).

She is dedicated to translating molecular research into impactful education strategies, clinical training initiatives, and interdisciplinary collaboration.

Research Focus : 

  • Neurodevelopmental Disorders
  • Fragile X–Associated Conditions
  • Curriculum Reform & Academic Leadership

Neurodevelopmental Disorders

0 +

Professional Speakers

0 +

Sponsers & Partners